Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Kwok, US
Alec G. Kwok, Remond, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20110225464 | RESILIENT CONNECTIVITY HEALTH MANAGEMENT FRAMEWORK - A framework is provided for diagnosing and resolving wireless connectivity-related issues. For example, some embodiments of the invention provide a “health monitor” which monitors and logs wireless connectivity-related events occurring on the device, the network, and the one or more resources to which the device is connected. The health monitor may analyze these events and/or other information to determine when a connectivity problem may have arisen, and if a problem is determined to be imminent or to have occurred, may initiate recovery procedures. In some embodiments, the monitoring of events, analysis to determine whether a connectivity problem has arisen, and the recovery from the problem occur transparently to the user. | 09-15-2011 |
Alton Kwok, Redmond, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20090300546 | Creation and suggestion of contact distribution lists - Techniques described herein allow for suggesting creation of distribution lists and suggesting use of distribution lists once they have been created. For instance, these techniques may track a frequency with which contacts (e.g., email addresses, phone numbers, screen names, etc.) are used with one another. The techniques may then suggest that a user create a distribution list that includes those contacts. Furthermore, once a contact has been associated with a particular distribution list, these techniques may suggest that a user send a message to this distribution list in response to the user selecting the contact (rather than the list) as a destination of the message. | 12-03-2009 |
Amy M. Kwok, Sturbridge, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20100297539 | ANTIREFLECTIVE HARD MASK COMPOSITIONS - The invention includes new organic-containing compositions that can function as an antireflective layer for an overcoated photoresist. Compositions of the invention also can serve effectively as a hard mask layer by exhibiting a sufficient plasma etch selectivity from an undercoated layer. Preferred compositions of the invention have a high Si content and comprise a blend of distinct resins. | 11-25-2010 |
Annette K. Kwok, Concord, NH US
| Patent application number | Description | Published |
|---|---|---|
| 20090270370 | FUSED HETEROCYCLIC COMPOUNDS - Certain fused pyrrole- and pyrazole-containing heterocyclic compounds are serotonin modulators useful in the treatment of serotonin-mediated diseases. | 10-29-2009 |
| 20110040088 | FUSED HETEROCYCLIC COMPOUNDS - Certain fused pyrrole- and pyrazole-containing heterocyclic compounds are serotonin modulators useful in the treatment of serotonin-mediated diseases. | 02-17-2011 |
Brandon Kwok, Burlington, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20100241912 | Fast bit-error rate calculation mode for QKD systems - A fast bit-error rate (F-BER) calculation mode for a QKD system is disclosed, wherein the method includes establishing versions of a sifted key in respective sifted-bits (SB) buffers in respective QKD stations (Alice and Bob). The method also includes sending Alice's version of the sifted key to Bob, and Bob performing a comparison of the two sifted key versions. The number of bit errors between the two sifted key versions relative to the length of the sifted key yields the F-BER. The F-BER is calculated much more quickly than the conventional BER calculation (“N-BER”), which involves performing a relatively complex error-correction algorithm. The F-BER calculation mode is particularly useful in quickly setting up and/or calibrating a QKD system, and can be repeated quickly to provide updated BER measurements after each QKD system adjustment. | 09-23-2010 |
Connie Kwok, Shoreline, WA US
Connie S. Kwok, Bothell, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20090197850 | Coatings Comprising Self-Assembled Molecular Structures - A coating for an implantable medical device is disclosed, the coating including a self-assembled molecular structure. The coating can be used for altering the release rate of a therapeutic substance from the implantable device. | 08-06-2009 |
| 20100189758 | COATING CONTAINING PEGYLATED HYALURONIC ACID AND A PEGYLATED NON-HYALURONIC ACID POLYMER - Provided herein are a method, which comprises implanting in a patient an implantable device comprising a coating that includes a PEGylated hyaluronic acid and a PEGylated non-hyaluronic acid biocompatible polymer and the methods of use thereof. | 07-29-2010 |
| 20100191325 | COATING CONTAINING PEGYLATED HYALURONIC ACID AND A PEGYLATED NON-HYALURONIC ACID POLYMER - Provided herein re a composition and a coating or a device (e.g., absorbable stent) that includes a PEGylated hyaluronic acid and a PEGylated non-hyaluronic acid biocompatible polymer and the methods of use thereof. | 07-29-2010 |
Kinghong Kwok, Willimantic, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20080199389 | Method and device for producing carbon nanotubes - Methods and devices for producing carbon nanotubes are disclosed herein. These methods and devices are based on chemical vapor deposition (CVD) in an open environment under atmospheric pressure, which eliminates the need for a vacuum chamber or evacuation process to remove oxygen and/or impurities prior to carbon nanotube growth. | 08-21-2008 |
K. Keith Kwok, Long Grove, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20080221048 | Lyophilized azithromycin formulation - The invention provides among other things a stable, sterile pharmaceutical formulation comprising lyophilized azithromycin and ethanol. The invention also provides a method of producing a stable, sterile pharmaceutical product comprising lyophilized azithromycin. The invention also provides a pharmaceutical dosage form comprising the pharmaceutical formulation, as well as a method of treating a disease in a patient comprising administering a solution of the pharmaceutical formulation to a patient. | 09-11-2008 |
| 20080221049 | Free-flowing lyophilized tobramycin formulation - The invention provides among other things a stable, sterile pharmaceutical formulation comprising lyophilized tobramycin, wherein the lyophilized tobramycin is in the form of a free-flowing powder. The invention also provides a method of producing a stable, sterile pharmaceutical product comprising lyophilized tobramycin. The invention also provides a pharmaceutical dosage form comprising the pharmaceutical formulation, as well as a method of treating a disease in a patient comprising administering a solution of the pharmaceutical formulation to a patient. | 09-11-2008 |
Pan Kwok, Sugar Land, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20100147510 | REMOTE LOGGING OPERATIONS ENVIRONMENT - In some embodiment, apparatus [ | 06-17-2010 |
Selma Sheungnam Kwok, Houston, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20100298117 | Catalyst Regeneration Process - This disclosure relates to a process for regenerating a catalyst composition, wherein the catalyst composition comprising a molecular sieve and at least 10 wt. % coke having a C/H ratio in the range of 0.26 to 5, the process comprising (a) contacting the catalyst composition with a first oxidative medium having oxygen and water at first conditions sufficient to form a first regenerated catalyst composition having at least 50 wt. % less coke than the catalyst composition; and then (b) contacting at least a portion of the first regenerated catalyst composition with a second oxidative medium having oxygen, and optionally water, at second conditions sufficient to form a second regenerated catalyst composition having at least 50 wt % less coke than the first regenerated catalyst composition, wherein the catalyst composition in step (a) and the first regenerated catalyst in step (b) have contacted total amount of water in the range of 1 to 50 weight water per weight of the second regenerated catalyst composition. | 11-25-2010 |
Shing Kwok, Alexandria, VA US
| Patent application number | Description | Published |
|---|---|---|
| 20110179529 | MODULATING LIGHT RESPONSE PATHWAYS IN PLANTS - Methods and materials for modulating low light and/or shade tolerance, and red light specific responses in plants are disclosed. For example, nucleic acids encoding low light and/or SD+EODFR-tolerance polypeptides are disclosed as well as methods for using such nucleic acids to transform plant cells. Also disclosed are plants having increased low light and/or SD+EODFR tolerance. | 07-21-2011 |
Simon C. Kwok, Attleboro, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20120019348 | METHOD AND APPARATUS FOR CONTROL OF FAILED THERMISTOR DEVICES - A thermistor device includes include supports, contacts and offset posts configured to assist the fracturing of failed thermistor “pills” and to distribute the fragments of the fractured pills into compartment away from electrically conductive contacts in order to minimize arcing and overheating. | 01-26-2012 |
Wai-Kwong Kwok, Evanston, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20100041559 | TUNABLE, SUPERCONDUCTING, SURFACE-EMITTING TERAHERZ SOURCE - A compact, solid-state THz source based on the driven Josephson vortex lattice in a highly anisotropic superconductor such as Bi | 02-18-2010 |
| 20100264312 | SUPERCONDUCTING SOURCE FOR TUNABLE COHERENT TERAHERTZ RADIATION - A system includes a solid state source of THz radiation and a detector. The source of THz radiation may be based on a superconducting material, such as materials containing one or more Josephson junctions (e.g. BSCCO). The source may include a crystal of superconducting material on which a mesa of superconducting material is formed. The resonant coupling between the Josephson oscillations and the fundamental cavity mode of the mesa may lead to synchronization of the Josephson junctions and emission of powerful THz radiation. The mesa may be formed and/or handled such that THz radiation can be emitted by the material without requiring application of an external magnetic field (e.g. the mesa may include a non-uniform compositional gradient, a non-uniform shape, may have radiation non-uniformly applied to the mesa, etc.). | 10-21-2010 |